As of July 2026 it remains an investigational drug in Eli Lilly's Phase 3 TRIUMPH program
There are three GLP-1 FDA decisions expected in early-mid 2026 Eli Lillys Mounjaro with a new indication to reduce the risk of major adverse cardiovascular events (MACE) in patients with T2DM Eli Lillys oral once-daily orforglipron for weight loss Novo Nordisks higher dose (7.2 mg) injectable once-weekly Wegovy for weight loss Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape
Mechanism of Action: What Does BPC 157 Do
Other Psychological Effects That Might Influence Mood or Behavior Several psychological effects can influence mood, behavior, or personality in Ozempic users
Users have reported a wide range of positive changes, including smoother, softer, and more radiant skin
Insulin resistance disrupts cell integrity, mitochondrial function, and inflammatory signaling in lymphatic endothelium